-
Mashup Score: 0Thyroid Hormone Administration Provides No Benefit on Transplant Rate, Graft Survival for Brain-Dead Donor Hearts - 5 month(s) ago
A trial randomizing brain-dead donor hearts to levothyroxine administration or saline has returned results challenging conventional wisdom on the topic, with data indicating thyroid hormone administration may provide no significant benefit.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 12Days alive and out of hospital following heart transplantation: A Retrospective Cohort Study - 6 month(s) ago
Patients with end-stage congestive heart failure that remain symptomatic despite optimal guideline-directed medical therapy may be candidates for orthotopic heart transplantation, mechanical circulatory support (MCS) devices as a bridge to transplant or as destination therapy, investigational studies, or palliative care.(1-3) While MCS as a bridge to transplant may improve hemodynamic function, stabilize or reverse end organ damage and improve wait-list mortality, the subsequent transplant procedure may be more complex and may impact post-transplantation outcomes.(2,4,5) While there is data to suggest that short-term mortality may be increased(6) and overall survival may be reduced in MCS as a bridge to transplant,(7) most studies demonstrate that both short term (typically defined as length of intensive care unit stay and overall hospital stay) and long-term outcomes (patient survival at 1, 3 and 5 years) are similar.(8-12)
Source: www.jcvaonline.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0
A better understanding will allow us to appropriately manage donors and recipients to reduce the complex interactions that lead to PGD. The development of an international consortium provides the opportunity for deep phenotyping and development of contemporary risk prediction models for PGD, which m …
Source: pubmed.ncbi.nlm.nih.govCategories: Cardiologists1, Latest HeadlinesTweet-
Happy to share that our review on Primary Allograft Dysfunction #PGD in #HeartTransplant has been published today in @CO_Organ_Transp - read it here: https://t.co/xbMg0LZ8wD @david_blitzer @FilioBillia #HannahCopeland @UHNTransplant @ColumbiaSurgery @lutheranhosp @IUMedSchool https://t.co/Hh3fl5V2X4
-
-
Mashup Score: 1A national pilot of donation after circulatory death (DCD) heart transplantation within the United Kingdom - 8 month(s) ago
The United Kingdom (UK) was one of the first countries to pioneer heart transplantation from donation after circulatory death (DCD) donors. To facilitate equity of access to DCD hearts by all UK heart transplant centers and expand the retrieval zone nationwide, a Joint Innovation Fund (JIF) pilot was provided by NHS Blood and Transplant (NHSBT) and NHS England (NHSE). The activity and outcomes of this national DCD heart pilot program are reported.
Source: www.jhltonline.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Overhaul of ‘calcified’ US organ transplant system can expand donor pool, save lives - 10 month(s) ago
Despite an expanded availability of donor hearts, there remains a shortage of available donor organs for people in need of transplantation, and many experts point to widespread inefficiencies with the U.S. organ transplant system.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Heart transplant is the most effective treatment for end-stage HF but it is also the scarcest of HF therapies — particularly for patients from underrepresented racial and ethnic groups.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
Heart transplant is the most effective treatment for end-stage HF but it is also the scarcest of HF therapies — particularly for patients from underrepresented racial and ethnic groups.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
Heart transplant is the most effective treatment for end-stage HF but it is also the scarcest of HF therapies — particularly for patients from underrepresented racial and ethnic groups.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0With heart transplant advances, a quest for ‘holy grail’ of tolerance, improved outcomes - 10 month(s) ago
Heart transplantation is considered standard therapy for patients with end-stage HF, and survival and the availability of donor hearts have continued to improve over time.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0With heart transplant advances, a quest for ‘holy grail’ of tolerance, improved outcomes - 10 month(s) ago
Heart transplantation is considered standard therapy for patients with end-stage HF, and survival and the availability of donor hearts have continued to improve over time.
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
A new study from @brainbleedmd and colleagues found that the administration of levothyroxine did not significantly improve rate of transplant for brain-dead donor hearts. Learn more about this potential practice-shifting trial: https://t.co/LuR4YqbnM6 #HeartTransplant https://t.co/IWPHiZqSak